Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2017-03-27

Clinical Trial Update: Surveillance for Early Liver Injuries Caused by Xianlin Gubao Granule

View source ↗

Summary

Ongoing safety surveillance is being conducted to monitor potential early liver injuries associated with Xianlin Gubao Granule.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xianlin Gubao Granule

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Drug-Induced Liver Injury | Status: UNKNOWN